Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen

On Friday, March 21, 2025, the Cathie Wood-led Ark Invest made some notable trades, including significant buys and sells.

The total value of the shares bought, based on the last close price of $27.65, is approximately $1.89 million.

The BEAM Trade: Ark Invest’s ARKK and Ark Genomic Revolution ETF (BATS:ARKG) funds bought a total of 28,717 shares of Beam Therapeutics Inc.

The total value of the shares bought, based on the last close price of $23.3, is approximately $669,106.

The PACB Trade: Ark Invest’s ARKK fund bought a whopping 243,300 shares of Pacific Biosciences of California Inc.

The total value of the shares bought, based on the last close price of $1.3, is approximately $316,290.

Other Key Trades:

  • Illumina Inc: Ark Invest sold a total of 42,616 shares through ARKK and ARKG.
  • Absci Corp: Ark Invest’s bought 71,392 shares through ARKG.
  • Repare Therapeutics: Ark Invest sold 54,786 shares through ARKG.
  • Amgen Inc: Ark Invest sold 990 shares through ARKG.
  • Veeva Systems Inc: Ark Invest sold 1,322 shares through ARKG.

Read Next:

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo courtesy: Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.